Information Collection: Medical Use of Byproduct Material, 84835-84836 [2023-26718]

Download as PDF Federal Register / Vol. 88, No. 233 / Wednesday, December 6, 2023 / Notices The NEA is particularly interested in comments which: • Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; • Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information including the validity of the methodology and assumptions used; • Enhance the quality, utility, and clarity of the information to be collected; and • Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. SUPPLEMENTARY INFORMATION: Dated: November 30, 2023. RaShaunda Thomas, Deputy Director, Office of Administrative Services & Contracts, National Endowment for the Arts. Rockville, Maryland. Dated: November 30, 2023. Edward R. Hawkens, Chief Administrative Judge, Atomic Safety and Licensing Board Panel. [FR Doc. 2023–26715 Filed 12–5–23; 8:45 am] BILLING CODE 7590–01–P NUCLEAR REGULATORY COMMISSION [NRC–2023–0065] [FR Doc. 2023–26710 Filed 12–5–23; 8:45 am] BILLING CODE 7537–01–P Information Collection: Medical Use of Byproduct Material NUCLEAR REGULATORY COMMISSION AGENCY: [Docket Nos. 50–250–SLR–2 and 50–251– SLR–2; ASLBP No. 24–981–01–SLR–BD01] Florida Power & Light Company; Establishment of Atomic Safety and Licensing Board Florida Power & Light Company (Turkey Point Nuclear Generating Units 3 and 4) This proceeding involves the twentyyear subsequent license renewal of Renewed Facility Operating Licenses DPR–31 and DPR–41, which currently authorize Florida Power & Light Company to operate Turkey Point Nuclear Generating Units 3 and 4 until, respectively, July 19, 2032 and April 10, 2033. In response to a notice published in the Federal Register, see 88 FR 62110 (Sept. 8, 2023), Miami Waterkeeper filed a hearing request. VerDate Sep<11>2014 20:52 Dec 05, 2023 Jkt 262001 Nuclear Regulatory Commission. ACTION: Notice of submission to the Office of Management and Budget; request for comment. The U.S. Nuclear Regulatory Commission (NRC) has recently submitted a request for renewal of an existing collection of information to the Office of Management and Budget (OMB) for review. The information collection is entitled ‘‘Medical Use of Byproduct Material.’’ DATES: Submit comments by January 5, 2024. Comments received after this date will be considered if it is practical to do so, but the Commission is able to ensure consideration only for comments received on or before this date. ADDRESSES: Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to https://www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under Review— Open for Public Comments’’ or by using the search function. FOR FURTHER INFORMATION CONTACT: David C. Cullison, NRC Clearance Officer, U.S. Nuclear Regulatory SUMMARY: Pursuant to delegation by the Commission, see 37 FR 28710 (Dec. 29, 1972), and the Commission’s regulations, see, e.g., 10 CFR 2.104, 2.105, 2.300, 2.309, 2.313, 2.318, 2.321, notice is hereby given that an Atomic Safety and Licensing Board (Board) is being established to preside over the following proceeding: lotter on DSK11XQN23PROD with NOTICES1 The Board is comprised of the following Administrative Judges: Emily I. Krause, Chair, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001 Dr. Sue H. Abreu, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001 Dr. Michael F. Kennedy, Atomic Safety and Licensing Board Panel, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001 All correspondence, documents, and other materials shall be filed in accordance with the NRC E-Filing rule. See 10 CFR 2.302. PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 84835 Commission, Washington, DC 20555– 0001; telephone: 301–415–2084; email: Infocollects.Resource@nrc.gov. SUPPLEMENTARY INFORMATION: I. Obtaining Information and Submitting Comments A. Obtaining Information Please refer to Docket ID NRC–2023– 0065 when contacting the NRC about the availability of information for this action. You may obtain publicly available information related to this action by any of the following methods: • Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC–2023–0065. • NRC’s Agencywide Documents Access and Management System (ADAMS): You may obtain publicly available documents online in the ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/ adams.html. To begin the search, select ‘‘Begin Web-based ADAMS Search.’’ For problems with ADAMS, please contact the NRC’s Public Document Room (PDR) reference staff at 1–800–397–4209, at 301–415–4737, or by email to PDR.Resource@nrc.gov. The supporting statement and burden spreadsheet are available in ADAMS under Accession Nos. ML23284A132 and ML23284A131. • NRC’s PDR: The PDR, where you may examine and order copies of publicly available documents, is open by appointment. To make an appointment to visit the PDR, please send an email to PDR.Resource@nrc.gov or call 1–800–397–4209 or 301–415– 4737, between 8 a.m. and 4 p.m. eastern time (ET), Monday through Friday, except Federal holidays. • NRC’s Clearance Officer: A copy of the collection of information and related instructions may be obtained without charge by contacting the NRC’s Clearance Officer, David C. Cullison, Office of the Chief Information Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555–0001; telephone: 301–415–2084; email: Infocollects.Resource@nrc.gov. B. Submitting Comments Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to https://www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under Review— Open for Public Comments’’ or by using the search function. The NRC cautions you not to include identifying or contact information in comment submissions that you do not E:\FR\FM\06DEN1.SGM 06DEN1 84836 Federal Register / Vol. 88, No. 233 / Wednesday, December 6, 2023 / Notices lotter on DSK11XQN23PROD with NOTICES1 want to be publicly disclosed in your comment submission. All comment submissions are posted at https:// www.regulations.gov and entered into ADAMS. Comment submissions are not routinely edited to remove identifying or contact information. If you are requesting or aggregating comments from other persons for submission to the OMB, then you should inform those persons not to include identifying or contact information that they do not want to be publicly disclosed in their comment submission. Your request should state that comment submissions are not routinely edited to remove such information before making the comment submissions available to the public or entering the comment into ADAMS. II. Background Under the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. chapter 35), the NRC recently submitted a request for renewal of an existing collection of information to OMB for review entitled, 10 CFR part 35 ‘‘Medical Use of Byproduct Material.’’ The NRC hereby informs potential respondents that an agency may not conduct or sponsor, and that a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. The NRC published a Federal Register notice with a 60-day comment period on this information collection on August 1, 2023, 88 FR 50182. 1. The title of the information collection: 10 CFR part 35, Medical Use of Byproduct Material. 2. OMB approval number: 3150–0010. 3. Type of submission: Extension. 4. The form number, if applicable: Not applicable. 5. How often the collection is required or requested: Reports of medical events, doses to an embryo/fetus or nursing child, or leaking source are reportable on occurrence. A specialty board certifying entity desiring to be recognized by the NRC must submit a one-time request for recognition and infrequently revise the information. 6. Who will be required or asked to respond: Physicians and medical institutions holding an NRC license authorizing the administration of byproduct material or radiation from this material to humans for medical use. A specialty board certification entity desiring to have its certifying process and board certificate recognized by NRC. 7. The estimated number of annual responses: 313,994 (234,284 reporting responses + 7,327 recordkeepers + 72,383 third party disclosure responses). VerDate Sep<11>2014 20:52 Dec 05, 2023 Jkt 262001 8. The estimated number of annual respondents: 7,340 (862 NRC licensees + 6,465 Agreement State licensees + 13 specialty board certification entity). 9. The estimated number of hours needed annually to comply with the information collection requirement or request: 1,117,570 hours (61,807 reporting + 1,043,235 recordkeeping + 12,528 third party disclosure). 10. Abstract: Part 35 of title 10 of the Code of Federal Regulations, ‘‘Medical Use of Byproduct Material,’’ contains NRC’s requirements and provisions for the medical use of byproduct material and for issuance of specific licenses authorizing the medical use of this material. These requirements and provisions provide for the radiation safety of workers, the general public, patients, and human research subjects. Part 35 contains mandatory requirements that apply to NRC licensees authorized to administer byproduct material or radiation to humans for medical use. These requirements also provide voluntary provisions for specialty boards to apply to have their certification processes recognized by the NRC so that their board-certified individuals can use the certifications as proof of training and experience. Dated: November 30, 2023. For the Nuclear Regulatory Commission. David C. Cullison, NRC Clearance Officer, Office of the Chief Information Officer. [FR Doc. 2023–26718 Filed 12–5–23; 8:45 am] BILLING CODE 7590–01–P OFFICE OF PERSONNEL MANAGEMENT Submission for Review: Initial Certification of Full-Time School Attendance, RI 25–41 Office of Personnel Management. ACTION: 30-Day notice and request for comments. AGENCY: The Office of Personnel Management (OPM), Retirement Services, offers the general public and other Federal agencies the opportunity to comment on the following expiring information collection (ICR), without change: Initial Certification of Full-Time School Attendance, RI 25–41. OPM uses RI 25–41 to determine if a child is eligible to receive survivor benefits. DATES: Comments are encouraged and will be accepted until January 5, 2024. ADDRESSES: Written comments and recommendations for the proposed SUMMARY: PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 information collection should be sent within 30 days of publication of this notice to https://www.reginfo.gov/ public/do/PRAMain. Find this particular information collection by selecting ‘‘Currently under Review— Open for Public Comments’’ or by using the search function or fax to (202) 395– 6974. FOR FURTHER INFORMATION CONTACT: A copy of this information collection, with applicable supporting documentation, may be obtained by contacting the Retirement Services Publications Team, Office of Personnel Management, 1900 E Street NW, Room 3316–L, Washington, DC 20415, Attention: Cyrus S. Benson, or sent via electronic mail to Cyrus.Benson@opm.gov or faxed to (202) 606–0910 or via telephone at (202) 936–0401. SUPPLEMENTARY INFORMATION: As required by the Paperwork Reduction Act of 1995, OPM is soliciting comments for this collection (OMB No. 3206–0099). This information collection was previously published in the Federal Register on May 3, 2023, at 88 FR 27929, allowing for a 60-day public comment period. No comments were received for this collection. The purpose of this notice is to allow an additional 30 days for public comments. OPM is particularly interested in comments that: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. RI 25–41, Initial Certification of FullTime School Attendance is used to determine whether a child is unmarried and a full-time student in a recognized school. OPM must determine this in order to pay survivor annuity benefits to children who are age 18 or older under 5 U.S.C. 8341(A)(4) and chapter 84, section 8441(4)(C). E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 88, Number 233 (Wednesday, December 6, 2023)]
[Notices]
[Pages 84835-84836]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-26718]


-----------------------------------------------------------------------

NUCLEAR REGULATORY COMMISSION

[NRC-2023-0065]


Information Collection: Medical Use of Byproduct Material

AGENCY: Nuclear Regulatory Commission.

ACTION: Notice of submission to the Office of Management and Budget; 
request for comment.

-----------------------------------------------------------------------

SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) has recently 
submitted a request for renewal of an existing collection of 
information to the Office of Management and Budget (OMB) for review. 
The information collection is entitled ``Medical Use of Byproduct 
Material.''

DATES: Submit comments by January 5, 2024. Comments received after this 
date will be considered if it is practical to do so, but the Commission 
is able to ensure consideration only for comments received on or before 
this date.

ADDRESSES: Written comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to https://www.reginfo.gov/public/do/PRAMain. Find this 
particular information collection by selecting ``Currently under 
Review--Open for Public Comments'' or by using the search function.

FOR FURTHER INFORMATION CONTACT: David C. Cullison, NRC Clearance 
Officer, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001; 
telephone: 301-415-2084; email: [email protected].

SUPPLEMENTARY INFORMATION:

I. Obtaining Information and Submitting Comments

A. Obtaining Information

    Please refer to Docket ID NRC-2023-0065 when contacting the NRC 
about the availability of information for this action. You may obtain 
publicly available information related to this action by any of the 
following methods:
     Federal Rulemaking Website: Go to https://www.regulations.gov and search for Docket ID NRC-2023-0065.
     NRC's Agencywide Documents Access and Management System 
(ADAMS): You may obtain publicly available documents online in the 
ADAMS Public Documents collection at https://www.nrc.gov/reading-rm/adams.html. To begin the search, select ``Begin Web-based ADAMS 
Search.'' For problems with ADAMS, please contact the NRC's Public 
Document Room (PDR) reference staff at 1-800-397-4209, at 301-415-4737, 
or by email to [email protected]. The supporting statement and 
burden spreadsheet are available in ADAMS under Accession Nos. 
ML23284A132 and ML23284A131.
     NRC's PDR: The PDR, where you may examine and order copies 
of publicly available documents, is open by appointment. To make an 
appointment to visit the PDR, please send an email to 
[email protected] or call 1-800-397-4209 or 301-415-4737, between 8 
a.m. and 4 p.m. eastern time (ET), Monday through Friday, except 
Federal holidays.
     NRC's Clearance Officer: A copy of the collection of 
information and related instructions may be obtained without charge by 
contacting the NRC's Clearance Officer, David C. Cullison, Office of 
the Chief Information Officer, U.S. Nuclear Regulatory Commission, 
Washington, DC 20555-0001; telephone: 301-415-2084; email: 
[email protected].

B. Submitting Comments

    Written comments and recommendations for the proposed information 
collection should be sent within 30 days of publication of this notice 
to https://www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under Review--Open for 
Public Comments'' or by using the search function.
    The NRC cautions you not to include identifying or contact 
information in comment submissions that you do not

[[Page 84836]]

want to be publicly disclosed in your comment submission. All comment 
submissions are posted at https://www.regulations.gov and entered into 
ADAMS. Comment submissions are not routinely edited to remove 
identifying or contact information.
    If you are requesting or aggregating comments from other persons 
for submission to the OMB, then you should inform those persons not to 
include identifying or contact information that they do not want to be 
publicly disclosed in their comment submission. Your request should 
state that comment submissions are not routinely edited to remove such 
information before making the comment submissions available to the 
public or entering the comment into ADAMS.

II. Background

    Under the provisions of the Paperwork Reduction Act of 1995 (44 
U.S.C. chapter 35), the NRC recently submitted a request for renewal of 
an existing collection of information to OMB for review entitled, 10 
CFR part 35 ``Medical Use of Byproduct Material.'' The NRC hereby 
informs potential respondents that an agency may not conduct or 
sponsor, and that a person is not required to respond to, a collection 
of information unless it displays a currently valid OMB control number.
    The NRC published a Federal Register notice with a 60-day comment 
period on this information collection on August 1, 2023, 88 FR 50182.
    1. The title of the information collection: 10 CFR part 35, Medical 
Use of Byproduct Material.
    2. OMB approval number: 3150-0010.
    3. Type of submission: Extension.
    4. The form number, if applicable: Not applicable.
    5. How often the collection is required or requested: Reports of 
medical events, doses to an embryo/fetus or nursing child, or leaking 
source are reportable on occurrence. A specialty board certifying 
entity desiring to be recognized by the NRC must submit a one-time 
request for recognition and infrequently revise the information.
    6. Who will be required or asked to respond: Physicians and medical 
institutions holding an NRC license authorizing the administration of 
byproduct material or radiation from this material to humans for 
medical use. A specialty board certification entity desiring to have 
its certifying process and board certificate recognized by NRC.
    7. The estimated number of annual responses: 313,994 (234,284 
reporting responses + 7,327 recordkeepers + 72,383 third party 
disclosure responses).
    8. The estimated number of annual respondents: 7,340 (862 NRC 
licensees + 6,465 Agreement State licensees + 13 specialty board 
certification entity).
    9. The estimated number of hours needed annually to comply with the 
information collection requirement or request: 1,117,570 hours (61,807 
reporting + 1,043,235 recordkeeping + 12,528 third party disclosure).
    10. Abstract: Part 35 of title 10 of the Code of Federal 
Regulations, ``Medical Use of Byproduct Material,'' contains NRC's 
requirements and provisions for the medical use of byproduct material 
and for issuance of specific licenses authorizing the medical use of 
this material. These requirements and provisions provide for the 
radiation safety of workers, the general public, patients, and human 
research subjects. Part 35 contains mandatory requirements that apply 
to NRC licensees authorized to administer byproduct material or 
radiation to humans for medical use. These requirements also provide 
voluntary provisions for specialty boards to apply to have their 
certification processes recognized by the NRC so that their board-
certified individuals can use the certifications as proof of training 
and experience.

    Dated: November 30, 2023.

    For the Nuclear Regulatory Commission.
David C. Cullison,
NRC Clearance Officer, Office of the Chief Information Officer.
[FR Doc. 2023-26718 Filed 12-5-23; 8:45 am]
BILLING CODE 7590-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.